3Li J.Rayner CR. Nation RL, et al. Heteroresistance to colistin in muhidrug-resistant Acinctobacter baumannii[J]. Antimicrob Agents Chemother. 206,50(9 ) : 2946-2950. 被引量：1
4Hermscn ED. Sullivan C J, Rotschafer JC. Polymyxins: pharma cologv,pharmacokinetics pharmacodynamics.and clinical applications[J]. Infect Dis Clin North Am,2003.17(3):545-562. 被引量：1
5Gales AC,Jones RN,Sader HS. Global assessment of the anti microbial aclivity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001 2004)[J]. Clin Microbiol Infect. 2006,12(4):315-321. 被引量：1
6Li J. Nation RL, Milne RW, etal. Evaluation of colistin as an agem againsl multi resistant Gram-negative bacteria[J]. Int J Antimicrob Agents,2005,25(1): 11-25. 被引量：1
2[1]O' Reilly M, Newcomb D E, Remck D. Endotoxin sepsis, and the primrose path[J]. Shock, 1999, 12(6): 411-420. 被引量：1
3[2]Andrew M, Calvin B. Reversal of postburn immunosuppression with low dose polymyxin B[J]. J Trauma, 1986, 26(11): 995-998. 被引量：1
4[3]Bucklin S E, Lake P, Logdberg L, et al. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia [ J ].Antimicro Agents Chemother, 1995, 39(7): 1462 - 1466. 被引量：1
5[4]Aoki H, Kodama M, Tani T, et al. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B immobilized fiber [ J ]. Am J Surg, 1994, 167(4): 412 - 417. 被引量：1
6[5]Tsuzuki H, Tani T, Ueyama H, et al. Lipopolysaccharide: Neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappB in peripheral blood mononuclear cells, even during activation[J]. J Surg Res,2001, 100(1): 127-134. 被引量：1
5OBRITSCH M D, FISH D N, MACLAREN R, et al.Nosocomial infection due to multidrug-resisitant pseudomonas aeruginosa: epidemiology and treatment options[ J]. Pharmacotherapy,2005,25(10) :1353. 被引量：1
6TAM T V,NQ S Y. The in vitro activity of colistin in gram- negtive bacteria [ J ]. Singapore Med J, 2006,47 ( 7 ) : 621 - 624. 被引量：1
7EVANS M E, FEOLA D J, RAPP R P. Polymyxin B sulfate and colistin old antibiotics for emerging multiresistant gram- negtive bacteria [ J ]. Ann Pharmacother, 1999,33 : 960 - 967. 被引量：1
8ELIZABETH D H, CHRISTOPHER J S, JOHN C R. Poly myxin : pharmacology, pharmacokinetics, pharmacod- ynamics, and clinical applications [ J ]. Infect Dis Clin N Am ,2003,17:545-562. 被引量：1
9PLACHOURAS D, KARVANEN M, FRIBERG L E, et al.Population pharmacokinetic analysis of colistin methanesul- fonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria [ J ]. Antimicrob Agents Chemother, 2009,53 ( 8 ) : 3430 -3436. 被引量：1
10KEE S, CHEONG H, PARK J, et al. Use of colistin against muhidrug resisitant pseudomonas and acinetobacter species [ C/CD] 47^th interscience conference on antimicrobial agent and chemotherapy [ M ]. Chicago: American Society for Microbiology, 2006 : 587. 被引量：1
